Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2013 2
2014 1
2016 1
2017 2
2018 2
2019 2
2020 1
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy.
Barra J, Cerda-Infante J, Sandoval L, Gajardo-Meneses P, Henriquez JF, Labarca M, Metz C, Venegas J, Retamal C, Oyanadel C, Cancino J, Soza A, Cuello MA, Roa JC, Montecinos VP, Gonzalez A. Barra J, et al. Among authors: oyanadel c. Cancers (Basel). 2021 Jul 20;13(14):3622. doi: 10.3390/cancers13143622. Cancers (Basel). 2021. PMID: 34298835 Free PMC article.
Galectin-8 Favors the Presentation of Surface-Tethered Antigens by Stabilizing the B Cell Immune Synapse.
Obino D, Fetler L, Soza A, Malbec O, Saez JJ, Labarca M, Oyanadel C, Del Valle Batalla F, Goles N, Chikina A, Lankar D, Segovia-Miranda F, Garcia C, Léger T, Gonzalez A, Espéli M, Lennon-Duménil AM, Yuseff MI. Obino D, et al. Among authors: oyanadel c. Cell Rep. 2018 Dec 11;25(11):3110-3122.e6. doi: 10.1016/j.celrep.2018.11.052. Cell Rep. 2018. PMID: 30540943 Free PMC article.
Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in Madin-Darby canine kidney cells.
Oyanadel C, Holmes C, Pardo E, Retamal C, Shaughnessy R, Smith P, Cortés P, Bravo-Zehnder M, Metz C, Feuerhake T, Romero D 5th, Roa JC, Montecinos V, Soza A, González A. Oyanadel C, et al. Mol Biol Cell. 2018 Mar 1;29(5):557-574. doi: 10.1091/mbc.E16-05-0301. Epub 2018 Jan 3. Mol Biol Cell. 2018. PMID: 29298841 Free PMC article.
Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
Pardo E, Cárcamo C, Uribe-San Martín R, Ciampi E, Segovia-Miranda F, Curkovic-Peña C, Montecino F, Holmes C, Tichauer JE, Acuña E, Osorio-Barrios F, Castro M, Cortes P, Oyanadel C, Valenzuela DM, Pacheco R, Naves R, Soza A, González A. Pardo E, et al. Among authors: oyanadel c. PLoS One. 2017 Jun 26;12(6):e0177472. doi: 10.1371/journal.pone.0177472. eCollection 2017. PLoS One. 2017. PMID: 28650992 Free PMC article.
Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.
Macanas-Pirard P, Broekhuizen R, González A, Oyanadel C, Ernst D, García P, Montecinos VP, Court F, Ocqueteau M, Ramirez P, Nervi B. Macanas-Pirard P, et al. Among authors: oyanadel c. Oncotarget. 2017 Apr 4;8(14):23073-23086. doi: 10.18632/oncotarget.14981. Oncotarget. 2017. PMID: 28160570 Free PMC article.
17 results